A Study of Olomorasib (LY3537982) in Healthy Participants
Phase 1
18–55
1 site in FL
Why this study is shown
What this study is about
This Phase 1 study is testing Fluconazole in people with healthy volunteers. The primary outcome being measured is Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of Olomorasib.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
fluconazole
oral (Oral Tablet)
Primary: Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of Olomorasib, Pharmacokinetics (PK): Maximum Concentration (Cmax) of Olomorasib